Hong Kong Exchanges and Clearing (HKEX) will launch five new weekly stock options and a Hang Seng Biotech Index Futures ...

George Tidmarsh, the FDA's top drug regulator, has been placed on leave after being accused of abusing his regulatory ...

Intellia Therapeutics is featured in Cathie Wood's portfolio and has a high Wall Street price target. The company's leading candidates look somewhat promising, but one of them just hit a major setback ...

Biotech company Amgen (NASDAQ:AMGN) will be reporting earnings this Tuesday after market close. Here’s what to look for.

Viking Therapeutics (VKTX) has captured investor attention with its recent stock movement, delivering a 28% gain over the past month. This comes as traders revisit the company’s ongoing expansion in ...

And I do have several favorite stocks that fit that description. My top growth stock to buy in November is one that I've ...

Viking Therapeutics is mispriced due to the successful but misunderstood clinical results of their oral GLP-1 treatment. Read ...

To overcome this challenge, it will take farmers like me. We can’t fight in the court of law, but we can make our voices heard in the court of public opinion.

Novo Nordisk attempts to acquire weight-loss drug company Metsera during government shutdown, potentially avoiding FTC ...

Dutch biotech Argenx is hoping to build a portfolio of autoimmune treatments around Vyvgart, which received FDA approval in 2021 as a treatment for myasthenia gravis. We think the drug will see peak ...

Krystal Biotech Inc. advanced stock charts by Barron's. View KRYS historical stock data and compare to other stocks, and exchanges.

Tim Boreham catches up with Cynata Therapeutics CEO Dr Kilian Kelly to talk the stem cell industry as the company ... Read ...